baber/WOPTO huggingface dataset:
Patent JP-2937482-B2 (JP)
IPC: G01D5/18
Filed: 1995-05-04
Granted: 1999-08-23
Abstract: A leakproof plastic zipper with integrated end stops for a zipper slider particularly suited for thermoplastic bags. An increased flange height above the interlocking elements of the zipper and an increased plow depth on the separator of the slider extending down between the flanges provide a means of stopping the travel of the slider past the ends of the zipper. The separator structure depending from the slider has a configuration in vertical cross-section corresponding to an inverted T, the horizontal portion of the T having the ends thereof adapted to be received in window structure in the flanges above the interlocking elements and adjacent one of the integrated end stops.
Patent JP-2851419-B2 (JP)
IPC: G02F1/136
Filed: 1990-01-02
Granted: 1999-01-27
Abstract: A liquid-crystal active dot-matrix display structure comprised of an array of pixel cells, which is implementable in integrated-circuit form, employs a spatial configuration for the respective pixel cells, each of which includes (1) a liquid-crystal element, (2) data line, (3) select line, and (4) drive-transistor, that both increases the proportion of the display-structure area occupied by the liquid-crystal elements themselves and also reduces parasitic capacitance, with respect to the spatial configurations employed by the prior art. The result is a brighter display that is particularly suitable for high-density displays (e.g., 1000 lines per inch in each dimension).
Patent JP-3825801-B2 (JP)
IPC: B41J29/42
Filed: 1996-06-06
Granted: 2006-09-27
Abstract: An interactive network device which interfaces a LAN to a peripheral that includes a front panel through which a user can affect status changes to the peripheral. Included in the interactive network device are a LAN interface which interfaces to the LAN and over which peripheral data is communicated, and a peripheral interface which interfaces to the peripheral and over which the peripheral data is communicated and the status of the peripheral data is received. A processor analyzes the status of the peripheral received over the peripheral interface so as to detect a predetermined sequence of status changes in the peripheral and, in response to detection of the predetermined sequence of status changes, (a) generates testpage information containing at least one of network information and interactive network device information and (b) outputs the generated testpage information.
Patent JP-H0678359-B2 (JP)
IPC: A61K39/385
Filed: 1985-08-02
Abstract: Antigens, immunogens, inocula, antibodies, diagnostic methods and systems relating to Epstein-Barr virus nuclear antigen (EBNA) are disclosed. Each of the compounds, compositions, methods or systems contains a synthetic, random copolymer polypeptide having about 6 to about 40 residues, or an antibody containing site that immunoreacts with such a polypeptide. The polypeptide includes the five amino acid residue sequence -Gly-R1-Gly-R2-Gly-, wherein R1 and R2 are the same or different amino acid residues selected from the group consisting of Ala, Asn, Arg, Gly, Leu, Pro, Ser, and Thr, with the provision that R1 and R2 are not both Gly. The polypeptide contains at least 25 mole percent Gly residues, and when linked to a carrier and introduced in an effective amount into a mammalian host is capable of inducing production of antibodies that immunoreact with EBNA.
Patent JP-2768831-B2 (JP)
IPC: D04H3/14
Filed: 1994-07-08
Granted: 1998-06-25
Abstract: PCT No. PCT/AT94/00087 Sec. 371 Date Jan. 4, 1995 Sec. 102(e) Date Jan. 4, 1995 PCT Filed Jul. 8, 1994 PCT Pub. No. WO95/02082 PCT Pub. Date Jan. 19, 1995Disclosed is a process for producing cellulose fibers having a decreased tendency to fibrillate. The process comprises the steps of extruding a solution of cellulose in a tertiary amine-oxide through spinning holes of a spinneret to form cellulose filaments, conducting the extruded cellulose filaments across an air gap of greater than 30 mm, and introducing the cellulose filaments into a precipitation bath. The process is carried out in a way that the mathematical expression 51.4+0.033xD+1937xM2 -7.18xT-0.094xL-2.50xF+0.045xF2, does not exceed the number 10. In the mathematical expression, D is the spinning hole diameter in  mu m, M is the dope output per hole in g/min, T is the titer of the individual filament in dtex, L is the length of the air gap in mm and F is the humidity of the air in the air gap in g of water/kg of air.
Patent JP-2512509-B2 (JP)
IPC: B29C48/06
Filed: 1987-07-13
Granted: 1996-07-03
Abstract: PCT No. PCT/GB87/00491 Sec. 371 Date Mar. 13, 1989 Sec. 102(e) Date Mar. 13, 1989 PCT Filed Jul. 13, 1987 PCT Pub. No. WO88/00521 PCT Pub. Date Jan. 28, 1988.A fishing line, or just a leader, has a core (11) which is coated by plastic material as it is pulled through an extruder (3) and then a quench bath (4) by a variable speed drive device (9). Very fine control can be exerted by laser devices (11, 12) before and after coating, and adjusting a selection of parameters such as drive speed, extrusion rate, pressure and temperature, and cooling. A double coating may be applied or additives mixed in the extruded plastics which will give a desired floating or sinking characteristic.
Patent JP-2811570-B2 (JP)
IPC: G06Q20/34
Filed: 1987-10-13
Granted: 1998-10-15
Abstract: PCT No. PCT/FR87/00397 Sec. 371 Date Jun. 1, 1988 Sec. 102(e) Date Jun. 1, 1988 PCT Filed Oct. 13, 1987 PCT Pub. No. WO88/02900 PCT Pub. Date Apr. 21, 1988.The storage cells are grouped into elements grouping at least two cells, each element being locatable by an address and having a parity. The balance of the card is the number of non-zero even elements with an address below the address of the odd element with the lowest address and which is called the "terminal". In order to debit the card and reduce said balance, the terminal is moved towards a lower address, while creating a new old element of lower address than the terminal to be displaced. In order to credit the card and increase this balance, the terminal is moved towards a higher address, while again giving to possible odd elements with a higher address than the terminal to be displaced an even character and while creating a new odd element with a higher address than the terminal to be displaced.
Patent JP-3005293-B2 (JP)
IPC: E04C3/04
Filed: 1992-11-25
Granted: 2000-01-31
Abstract: PCT No. PCT/CA92/00514 Sec. 371 Date Mar. 1, 1995 Sec. 102(e) Date Mar. 1, 1995 PCT Filed Nov. 25, 1992 PCT Pub. No. WO94/05872 PCT Pub. Date Mar. 17, 1994.A metal member having at least one edge formation, and a web extending from the edge formation, a plurality of generally triangular openings formed in the web at spaced intervals, the triangular formations being alternately reversed relative to one another, a plurality of generally diagonal struts extending between adjacent triangular openings, edge portions along either edge of the web portion, with the struts extending from one said edge portion to the other and merging integrally therewith, flange formations formed from the web around the generally triangular openings, and lying at an angle thereto, whereby to form the diagonal struts with a generally channel shaped cross section, and forming intermittent flanges along the web edges at the base of each triangular opening, the triangular openings defining generally curved corners, and, generally three-sided indentations formed in the web edge at the roots of each of the diagonal struts.
Patent JP-2881499-B2 (JP)
IPC: C07K19/00
Filed: 1992-10-27
Granted: 1999-04-12
Abstract: PCT No. PCT/GB92/01970 Sec. 371 Date Apr. 28, 1994 Sec. 102(e) Date Apr. 28, 1994 PCT Filed Oct. 27, 1992 PCT Pub. No. WO93/08837 PCT Pub. Date May 13, 1993A stabilized immunoglobulin composition comprises at least one immunoglobulin together with a stabilizing amount of a chelator of copper ions such as EDTA or citrate. Preferably the immunoglobulin is an antibody, for example, a recombinant CDR-grafted antibody. A process for enhancing the stability of an immunoglobulin comprises subjecting the immunoglobulin to a purification procedure capable of removing copper ions therefrom. Preferably, the immunoglobulin is rendered substantially free from detectable copper ions as determined, for example, by atomic absorption spectroscopy.
Patent JP-2789559-B2 (JP)
IPC: F27B7/04
Filed: 1994-08-30
Granted: 1998-08-20
Abstract: A heating chamber for solid material, preferably a low-temperature carbonization drum for waste, is rotatable about its longitudinal axis and is equipped with a number of heating tubes that are disposed in an interior space and are aligned approximately parallel to one another. In order to ensure that only fine material can collect between the heating tubes and the inner wall surface of the heating chamber, the heating tubes, as viewed in cross-section, are disposed in a virtually closed row along the wall. Dummy tubes which are preferably easy to remove and preferably have the same diameter as the heating tubes, are located in this row, which may be circular.
Patent JP-3664726-B2 (JP)
IPC: A61N1/30
Filed: 1994-08-31
Granted: 2005-06-29
Abstract: An electrotransport delivery device utilizing reservoir buffering at a select pH ranges in order to reduce skin irritation and skin resistance is provided. Cathodic reservoirs are buffered to a pH of less than about 4, preferably to a pH in the range of about 2 to 4, while anodic reservoirs are buffered to a pH above about 4, preferably to a pH in the range of about 4 to 10. Another electrotransport delivery device utilizes a potassium sensor to monitor potassium efflux from the skin. Potassium efflux above a certain predetermined level has been found to be a precursor to skin irritation/erythema. Operation of the device is modified (eg, terminated) when the predetermined potassium efflux level is sensed.
Patent JP-4142741-B2 (JP)
IPC: C12N5/0783
Filed: 1996-08-23
Granted: 2008-09-03
Abstract: The subject invention pertains to novel methods and compositions for protecting cats from infection by a broad range of FIV strains using a multi-subtype FIV vaccine. Multi-subtype FIV vaccines comprising either cell free whole virus or cell lines infected with viruses are described. Methods for vaccinating cats with the subject vaccine compositions are also described. Cats vaccinated according to the methods and compositions of the subject invention exhibit protective humoral and cellular immune responses to FIV when challenged with homologous or heterologous strains of FIV. The subject invention also pertains to novel feline cell lines that are susceptible to infection by FIV and their methods of use.
Patent JP-4145953-B2 (JP)
IPC: C12Q1/68
Filed: 1994-10-24
Granted: 2008-09-03
Abstract: This invention provides a method of generating a subtracted cDNA library of a cell comprising: a) generating a cDNA library of the cell; b) isolating double-stranded DNAs from the cDNA library; c) releasing the double-stranded cDNA inserts from the double-stranded DNAs; d) denaturing the isolated double-stranded cDNA inserts; e) hybridizing the denatured double-stranded cDNA inserts with a labelled single-stranded nucleic acid molecules which are to be subtracted from the cDNA library; and f) separating the hybridized labeled single-stranded nucleic acid molecule from the double-stranded cDNA inserts, thereby generating a subtracted cDNA library of a cell. This invention also provides different uses of the subtracted library.
Patent JP-2709419-B2 (JP)
IPC: A61P7/08
Filed: 1991-07-24
Granted: 1998-02-04
Abstract: The present invention relates to a stable hemoglobin based composition having sufficiently low levels of methemoglobin to effectively function as an oxygen carrying solution upon administration to a patient made by the process comprising: a) adding an oxygenated or deoxygenated form of said blood substitute to an oxygen impermeable package, and b) storing said container at from between 5  DEG C to 45  DEG C for sufficient time to permit the autoreduction of methemoglobin. The stable hemoglobin based composition includes hemoglobin, modified hemoglobin and/or encapsulated hemoglobin. To effectively function as an oxygen carrying solution upon administration to a patient, the stable hemolobin based solution cannot have greater than about 50 % of said hemoglobin based solution in the methemoglobin form but, preferably no more than about 15 %. The invention further relates to a method to store a stable oxygen carrying solution according to the above discussed process.
Patent JP-2610222-B2 (JP)
IPC: G02F1/313
Filed: 1993-02-17
Granted: 1997-05-14
Abstract: PCT No. PCT/EP93/00370 Sec. 371 Date Sep. 12, 1994 Sec. 102(e) Date Sep. 12, 1994 PCT Filed Feb. 17, 1993 PCT Pub. No. WO93/17363 PCT Pub. Date Sep. 2, 1993An integrated optical switching device for switchably converting a fraction of a first guided mode signal into a second guided mode signal of different order is provided. Added to a passive mode converter (c) provided with a bimodal waveguide, in which the conversion can take place by a periodic coupling in coupling surfaces 1-N as a consequence of a specific geometry (f, g), are electrodes (10, 14) for switchably disrupting the coupling, as a consequence of which the conversion does or does not take place. Preferably, the optical switching device is constructed on semiconductor material and the modification is carried out by charge carrier injection. On/off and directional switches based on this are provided. As a result, the advantages of the present system are very good integrability, short length, no critical parameters in the manufacture, and operation at low control currents.
Patent JP-3935938-B2 (JP)
IPC: C07K14/78
Filed: 1997-01-03
Granted: 2007-06-27
Abstract: An method is disclosed for removing Type I collagen-containing tissue adjoining Type II collagen-containing animal tissue comprising treatment of unprocessed Type II collagen-containing tissue in an acidic solution in the presence of an acid proteinase and subjecting the mixture to moderate agitation for a period of time sufficient to cause digestion or separation of the Type I collagen-containing tissue from the Type II collagen-containing tissue. Also disclosed are methods for removing proteoglycans from Type II collagen-containing tissue.
Patent JP-3415843-B2 (JP)
IPC: H02G15/18
Filed: 1994-04-06
Granted: 2003-06-09
Abstract: PCT No. PCT/GB94/00731 Sec. 371 Date Oct. 5, 1995 Sec. 102(e) Date Oct. 5, 1995 PCT Filed Apr. 6, 1994 PCT Pub. No. WO94/23480 PCT Pub. Date Oct. 13, 1994An arrangement for delivering an elastic sleeve on to an electric cable comprises an elastic sleeve (20) expanded radially on to a hollow rigid tubular support tube (18) with a tubular mesh (22) of plastics material interposed therebetween. The mesh (22) extends beyond one end of the support tube (18) and is then fed back through its hollow center. The one end of the tube (18) is disposed adjacent the end of the cable, and the mesh (22) within the tube (18) is progressively pulled so as to invert the sleeve (20) on to the cable end.
Patent JP-3739407-B2 (JP)
IPC: A61F2/24
Filed: 1995-12-28
Granted: 2006-01-25
Abstract: This invention comprises a method of using tubular material (200) to replace a heart valve (118)(120)(162) during cardiac surgery. To create a replacement atrioventricular (mitral or tricuspid) valve (120)(160), the tube inlet is sutured to a valve annulus (121)(162) from which the native leaflets have been removed, and the tube outlet is sutured to papillary muscles (126)(128)(170) in the ventricle (112)(152). To create a semilunar (aortic or pulmonary) valve (118), the tube inlet is sutured to an annulus from which the native cusps have been removed, and the tube is either "tacked" at three points distally inside the artery, or sutured longitudinally along three lines; this allows the flaps of tissue between the three fixation points at the valve outlet to function as movable cusps. These approaches generate flow patterns that closely duplicate the flow patterns of native valves. A preferred tubular material (200) comprises submucosal tissue from the small intestine; this can be taken from the same patient who is undergoing the cardiac operation, to reduce antigenicity. Animal or cadaver intestinal tissue can also be used if properly treated, or a biocompatible synthetic tubular material can be used. This invention also discloses a properly treated intestinal tissue segment or synthetic tubular segment (500) suitable for implantation as a replacement heart valve, enclosed in a sealed sterile package (510). <IMAGE>
Patent JP-2843681-B2 (JP)
IPC: C07D211/90
Filed: 1995-03-06
Granted: 1999-01-06
Abstract: A method for the separation of R-(+)- and S-(-)-isomers of amlodipine (I) from mixtures thereof, which comprises the reaction of the mixture of isomers with either L- or D-tartaric acid in an organic solvent containing sufficient dimethyl sulphoxide (DMSO) for the precipitation of, respectively, a DMSO, solvate of an L-tartate salt of R-(+)-amlodipine, or a DMSO solvate of a D-tartrate salt of S-(-)-amlodipine.
Patent JP-3555086-B2 (JP)
IPC: C12N1/21
Filed: 1995-05-18
Granted: 2004-08-18
Abstract: DNA sequences coding for enzymes capable of facilitating the synthesis of linear □-1,4 glucans in plants, fungi and microorganisms. The invention relates to DNA sequences Coding for proteins having the enzymatic activity of an amylosucrase which allows the synthesis of linear □1,4 glucans from the substrate sucrose by bacteria, fungi and plants or in cell-free systems. The invention furthermore describes plasmids and bacteria containing these DNA sequences as well as processes for the production of plants and microorganisms capable of intracellularly or extracellularly expressing a polypeptide having amylosucrase activity. The invention furthermore relates to the production of pure fructose using proteins exhibiting the enzymatic activity of amylosucrase.
Patent JP-3407114-B2 (JP)
IPC: D21H11/00
Filed: 1996-04-04
Granted: 2003-05-19
Abstract: PCT No. PCT/EP96/01484 Sec. 371 Date Oct. 7, 1997 Sec. 102(e) Date Oct. 7, 1997 PCT Filed Apr. 4, 1996 PCT Pub. No. WO96/31647 PCT Pub. Date Oct. 10, 1996A method for producing extensible paper, comprising the following stages: feeding a mix of vegetable fibres to a kneader member, mixing the mix with water in the kneader, beating the fibres to obtain a pulp, transferring the beaten pulp into a flow chest, feeding the beaten pulp from the flow chest onto a paper web formation cloth with consequent reduction of the water percentage by gravity and vacuum, pressing the web, with consequent further reduction of its water content, initial drying of the paper web to a substantially constant moisture content of between 15% and 65%, compacting, final drying to a moisture content of between 15% and 4%, preferably 10%-8%, glazing, wherein: the beating stage is carried out by rubbing the fibres in a multistage unit to obtain a pulp having a degree of beating of at least 30 DEG  SR, the compacting stage is carried out between at least a pair of rollers of which one is of hard material comprising circunferential surface ribs and driven at greater speed, and the other is of soft material with a smooth surface and driven at lesser speed.
Patent JP-3825811-B2 (JP)
IPC: A61D7/00
Filed: 1998-01-09
Granted: 2006-09-27
Abstract: The present invention describes a device for the controlled release of active compounds in the gastrointestinal tract with delayed pyloric passage, having a component expandable on contact with gastric juice, which is surrounded by a polymer covering which is permeable to gastric juice and active compounds. The device contains at least one active compound which is present in a multiparticulate preparation which releases the active compound into the gastric juice with a delay. Compared with conventional pharmaceutical forms with delayed pyloric passage, the release of active compound from a device according to the invention can be better controlled; likewise the device can be easily rolled or folded and can be introduced into capsules without problems.
Patent ES-2321576-B2 (ES)
Title: Colector de energia solar termica.
Inventor: MARTINEZ-VAL PENALOSA JOSE MARIA
IPC: F24S10/40
Filed: 2008-12-31
Granted: 2009-10-13
Abstract: Colector de energía solar térmica, en el que un
panel absorbedor de radiación  solar, por dentro del cual circula el
fluido calorífero, se sitúa dentro  de un cajón paralelepipédico,
con una apertura con cubierta transparente  en su parte frontal que
puede duplicarse dejando un huelgo atmosférico  en medio, contando
la pared posterior del cajón con un sistema de juntas  y tanques
encastrados en la propia pared de modo que se asimilan las
dilataciones  y contracciones de los tubos verticales del panel y de
sus conexiones horizontales  mediante cambios suaves de curvatura de
codos de tubería y de minúsculos  giros de los tanques, añadiendo un
sistema de llenado del cajón con un  gas inerte, cuya presión puede
escogerse entre una milésima de atmósfera  y una atmósfera,
disponiéndose para ello de un circuito exterior de gas,  con tanques
de baja y alta presión, y compresor intermedio.
Patent ES-2552672-B2 (ES)
Title: Procedimiento de instalación, en un suelo o depósito de residuos, con elementos o compuestos contaminantes, de una barrera física multicapa para interrumpir flujos hídricos verticales
Inventor: GARCIA FERNANDEZ GREGORIO
IPC: E02D31/00
Filed: 2015-07-10
Granted: 2016-03-11
Abstract: Procedimiento de instalación, en un suelo (1) o depósito de residuos, con elementos o compuestos contaminantes, de una barrera física multicapa para interrumpir flujos hídricos verticales, que supone una optimización de eficiencia y coste. Comprende disponer primera (4), segunda (6), tercera (8), cuarta (10) y quinta (12) capas de áridos (4, 6, 8, 10, 12) consecutivas, de granulometrías alternadas respectivamente, de abajo a arriba, de tipo grava, arenas, grava, arenas y grava, así como intercalar una capa de un material separador (3, 5, 7, 9, 11), inmediatamente antes de cada capa de áridos (4, 6, 8, 10, 12), para evitar mezcla de materiales entre suelo (1) y la primera capa de áridos (4) y entre cada dos capas de áridos (4, 6, 8, 10, 12) consecutivas. Las capas de áridos segunda (6) y cuarta (10) son compactadas para evitar filtración, preferentemente de acuerdo con su valor máximo de compactación Proctor.
Patent AU-2001278431-B2 (AU)
Title: Mutated furin polypeptides having improved characteristics
Inventor: SCHLOKAT UWE
IPC: C12N15/09
Filed: 2001-05-25
Granted: 2006-08-10
Abstract: The present invention comprises a furin polypeptide having a modified amino acid sequence between the middle, homo-B-domain and the transmembrane domain compared to wild-type furin which retains proteolytic activity but is secreted at lower levels in cell culture compared to wild-type furin. Additionally, the invention includes nucleic acid molecules encoding such furin polypeptides, vectors and host cells comprising said nucleic acid molecules, compositions comprising said furin polypeptide and methods for producing such compositions.
Patent AU-2002232302-B2 (AU)
Title: Laminate material for the protection of body parts and device comprising such laminate
Inventor: MIJN LEONARDUS JOHANNES MARIA
IPC: D03D15/56
Filed: 2002-02-22
Granted: 2005-11-17
Abstract: A laminate material includes an upper layer (I) and a lower layer (II) which is joined to the upper layer over substantially the entire surface thereof. The upper layer (I) includes a thin layer of leather material ( 1 ), and the lower layer (II) is a material which can be stretched in two directions. The lower layer (II) includes at least one support layer ( 3 ) which is resilient in two directions and has at least two sorts of interwoven fibres, at least one type of fibres being produced from an elastic substance, as well as a layer ( 5 ) of a compressible substance which is joined to the support layer over substantially the entire surface thereof and is resilient in three mutually perpendicular directions. Such laminate material can be used in a device for protecting a body part of a human or an animal.